What is Myeloma?

Plasma cells are a type of white blood cell produced in the bone marrow, important for producing antibodies to fight infections. Myeloma begins when the DNA of a single plasma cell becomes damaged during its development, causing it to mutate into a cancerous cell. This abnormal cell then begins to multiply uncontrollably within the bone marrow, eventually crowding out the healthy red blood cells, white blood cells, and platelets that the body depends on. 

When abnormal plasma cells get accumulated in the bone marrow, they disrupt the production of healthy blood cells, compromise bone integrity, and place considerable strain on the kidneys and the immune system.

Unlike many other cancers, myeloma does not form a single lump or tumour. Instead, it spreads to multiple sites in the body where bone marrow is usually active, including the bones of the pelvis, skull, rib cage, arms, and legs. This is why the condition is most often referred to as 'multiple myeloma'.

What are the Types of Myeloma?

Multiple myeloma is classified in several ways, such as by immunoglobulin type, gene mutation, and disease stage. Here is an overview of the main types of cancer:

  1. Based on Disease Stage

    Myeloma is divided into two stages based on whether it is causing symptoms or damage to the body:

    • Smouldering Myeloma: At this stage, abnormal plasma cells and paraprotein are present in the body but have not yet caused any noticeable symptoms or damage to organs or tissues. Treatment is not usually required, but very close monitoring is essential, as the condition can progress. The risk of progression to active myeloma is highest within the first 5 years after diagnosis. After 5 years, the risk decreases, and some people never progress to needing treatment.
    • Active Myeloma: When myeloma becomes active, it begins to cause symptoms such as bone pain and fatigue and can lead to organ damage, including bone lesions and kidney problems. Treatment is required at this stage.
  2. Based on Immunoglobulin Type

    Each myeloma case produces only one type of abnormal protein, known as a paraprotein or M protein. Antibodies are made up of two types of chains- larger heavy chains and smaller light chains – and myeloma is named after the specific combination present. 

    • IgG Myeloma: The most common type, accounting for the majority of myeloma cases. It is named after the G-type heavy chain present in the abnormal antibody. It can occur in combination with either a kappa or lambda light chain.
    • IgA Myeloma: The second most common type, involving the A-type heavy chain. Like IgG, it occurs alongside either a kappa or lambda light chain.
    • IgD, IgE, and IgM Myeloma: These types involve the D, E, and M heavy chains, respectively, and are considerably rarer. IgD and IgE myeloma in particular are uncommon, and IgM myeloma is the rarest of all.
    • Light Chain Myeloma (Bence Jones Myeloma): In this type, the myeloma cells produce only the light chain portion of the antibody and not the heavy chain. 
    • Non-Secretory Myeloma: In rare cases, the myeloma cells produce little or no paraprotein at all, making the condition harder to detect through standard blood tests. 

How Common is Myeloma in India?

According to the Global Cancer Observatory (GLOBOCAN) 2020, the five-year prevalence of multiple myeloma in India is approximately 2.2 cases per 1,00,000 people, compared with 5.78 per 1,00,000 globally. The disease accounts for around 1.23% of all cancers in the country and is responsible for nearly 5,900 deaths every year.

Globally, the median age of diagnosis is about 70 years, but in India, patients are diagnosed around a decade earlier. The country’s younger population structure is partly to blame, researchers say. The incidence of myeloma in young adults in India was 8.5%, which was higher than what has been reported in Western studies. The most common symptoms at presentation are bone pain and bony lesions, occurring in the vast majority of patients at diagnosis. Renal failure is another big issue, especially in older patients.

What are the Symptoms of Myeloma?

In its early stages, multiple myeloma may produce no noticeable symptoms at all, which is part of what makes it difficult to detect. As the disease progresses, the following symptoms may appear:

  • Persistent bone pain, particularly in the back, spine, chest, hips, and rib cage.

  • Bones that fracture more easily than normal due to weakening caused by myeloma cells.

  • Overwhelming fatigue and weakness, often linked to anaemia.

  • Recurring or severe infections due to a weakened immune system.

  • Kidney problems caused by abnormal proteins and elevated calcium levels in the blood.

  • Increased thirst and frequent urination.

  • Nausea, constipation, and loss of appetite.

  • Unexplained weight loss.

  • Feeling a tingling sensation or numbness in hands and feet.

  • Mental fogginess or confusion.

What Causes Myeloma?

Myeloma begins when a plasma cell in the bone marrow undergoes a genetic mutation, causing it to behave abnormally. Instead of following the normal cycle of growth and death, the mutated cell begins dividing uncontrollably, producing large numbers of cancerous myeloma cells. 

As myeloma cells get collected in the bone marrow, the production of healthy red blood cells, white blood cells, and platelets gets disrupted and the body cannot function normally. Myeloma cells continue to produce antibodies, as normal plasma cells do, but the antibodies they make, known as M proteins, are abnormal and serve no useful purpose. Instead, they accumulate in the body and can damage the kidneys and other organs.

The cause of this sudden mutation is unknown. These mutations are acquired rather than inherited and develop after birth. They appear to develop spontaneously over a person's lifetime, which may explain why the disease is more commonly diagnosed in older adults.

Risk Factors of Myeloma

While the exact cause of myeloma is not fully understood, certain factors are known to increase the likelihood of developing the disease.

  • Older Age: Myeloma is primarily seen in those who have crossed the age of 50, with the majority of cases occurring in the late 60s.

  • Gender: Men are more likely to be diagnosed with multiple myeloma than women as per research.

  • Family History: Having a parent or sibling with myeloma may increase the risk, although the disease is not usually inherited.

  • Developing MGUS: MGUS is a condition where the plasma cells start producing M proteins. Those with MGUS have a greater chance of developing multiple myeloma over time.

  • Obesity: Research has linked being overweight to an increased risk of developing myeloma.

  • Exposure to Harmful Chemicals or Radiation: Long-term exposure to pesticides, fertilisers, radiation, or certain industrial chemicals and metals may increase the risk of developing myeloma.

  • High-Risk Occupations: Some studies suggest that people working in occupations with frequent exposure to chemicals or smoke, such as firefighting, may have a higher risk of developing myeloma.

What are the Complications of Myeloma?

If myeloma is not treated or progresses over time, it can affect several organs and body systems, leading to serious health complications.

  • Frequent Infections: Myeloma weakens the immune system, making the body more vulnerable to repeated infections, especially bacterial infections such as pneumonia.

  • Bone Damage: The disease can weaken bones, causing persistent bone pain, thinning of the bones, and increasing the risk of fractures.

  • Kidney Damage: Abnormal proteins produced by myeloma cells can harm the kidneys and, in severe cases, lead to kidney failure.

  • Anaemia: Myeloma can reduce the production of healthy red blood cells. This can cause anaemia, leading to tiredness, weakness, and other blood-related problems.

  • High Calcium Levels (Hypercalcaemia): Bone breakdown can release excess calcium into the bloodstream, resulting in hypercalcaemia, which may require urgent medical treatment.

  • Peripheral Neuropathy: Peripheral nerve damage can cause numbness, tingling, pain, or increased sensitivity in the hands and feet. This may result from the disease itself or its treatment.

  • Amyloidosis: Abnormal proteins produced by myeloma can accumulate in organs, interfering with their normal function.

  • Cryoglobulinaemia: Certain abnormal proteins may damage blood vessels and interfere with normal blood circulation.

  • Hyperviscosity Syndrome: Excess proteins in the blood can make it unusually thick, reducing blood flow and requiring emergency medical care.

  • Spinal Cord Compression: Weakened bones in the spine can press the spinal cord, leading to pain, weakness, or nerve-related problems that require immediate treatment.

When Should I See My Healthcare Provider?

If you have symptoms that may be a sign of myeloma, see your healthcare provider as soon as you can. Early diagnosis increases the chances of better treatment outcomes. If you have already been diagnosed, stay in regular touch with your doctor and tell them immediately if you develop any new or worsening symptoms or side effects of treatment. The doctor can also explain what symptoms to expect during treatment, which symptoms will need a routine appointment and which symptoms may need immediate emergency medical attention.

How is Myeloma Diagnosed?

Doctors diagnose myeloma by combining your medical history, physical examination, laboratory investigations, imaging studies, and bone marrow testing, as no single test can confirm the disease.

  1. Medical Checkup The first step is a discussion with a doctor about your symptoms, medical history, and family history of cancer (if any), along with a physical examination. If myeloma is suspected, you may be referred to a haematologist for further evaluation.

  2. Blood, Urine, and Imaging Tests Blood and urine tests help detect abnormal proteins produced by myeloma cells and assess blood cell counts, kidney function, and calcium levels. Imaging tests, like X-rays, CT scans, MRI scans, or PET scans, may be used to look for bone damage or tumours.

  3. Bone Marrow Biopsy A small sample of bone marrow, usually taken from the hip bone, is observed under a microscope to look for abnormal plasma cells and confirm the diagnosis. Doctors may analyse the bone marrow sample to identify genetic changes in the myeloma cells.

How is Myeloma Treated?

Treatment for myeloma depends on the stage of the cancer, the severity of symptoms, and the patient's overall health. Common treatment options include:

  • Monitoring: If myeloma is at an early stage and not causing symptoms, doctors may recommend regular blood and urine tests along with periodic check-ups to monitor the disease before starting treatment.

  • Targeted Therapy: These medicines target specific proteins or pathways in myeloma cells, helping destroy cancer cells while limiting damage to healthy tissues.

  • Immunotherapy: This treatment strengthens the body's immune system so it can better recognise and attack myeloma cells.

  • CAR T-Cell Therapy: In this advanced form of immunotherapy, a patient's own T cells are modified in a laboratory and returned to the body to identify and kill myeloma cells.

  • Chemotherapy: Powerful anti-cancer medicines are used to destroy rapidly growing myeloma cells and are often given before a stem cell transplant.

  • Corticosteroids: Steroid medicines help reduce inflammation and also work directly against myeloma cells. They are commonly used along with other treatments.

  • Stem Cell Transplant: This procedure replaces damaged bone marrow with healthy blood-forming stem cells, usually collected from the patient's own body. It is also called a ‘bone marrow transplant’.

  • Radiation Therapy: This therapy uses radiation to shrink tumours, relieve bone pain, and treat areas where the cancer has damaged the bones.

Can Myeloma be Prevented?

There is no guaranteed way to prevent myeloma because the exact reason why healthy plasma cells become cancerous is still not fully understood. However, here are a few things you can do:

  • Maintain a Healthy Weight: Being overweight is associated with an increased risk of myeloma, so maintaining a healthy body weight may be beneficial.

  • Follow a Healthy Lifestyle: Eat a balanced and nutritious diet, exercise regularly, avoid smoking, and limit alcohol consumption to support your overall health.

  • Minimise Exposure to Harmful Chemicals and Radiation: If possible, avoid unnecessary exposure to radiation and to chemicals such as certain pesticides, fertilisers, and other hazardous substances linked to a higher risk of myeloma.

  • Focus on Early Detection: Since most risk factors, such as age and family history, cannot be changed, paying attention to persistent symptoms and seeking timely medical evaluation can help with earlier diagnosis and treatment.

What is the Prognosis of Myeloma?

Although there is currently no permanent cure for myeloma, advances in treatment have significantly improved survival and quality of life for many patients. The prognosis looks different in every case, depending on the cancer stage, the person's overall health, and how well the cancer responds to treatment. 

In general, people diagnosed at an early stage tend to have a much better prognosis than those diagnosed after the disease has become more advanced. The overall five-year survival rate for myeloma is about 62%. However, when the condition is detected early, the five-year survival rate increases to around 80%. Many people are also able to live for 10 years or longer with appropriate treatment and regular follow-up care.

Does Health Insurance Cover Myeloma?

Yes, health insurance covers the treatment of blood cancers like myeloma. Most policies cover hospital room rent, surgeon's fees, medicines, diagnostic tests, ambulance expenses, and specified pre- and post-hospitalisation expenses.

Critical illness plans also cover blood cancers, offering a lump-sum payment that you can use for treatment costs. You become eligible for a payout after diagnosis, subject to a waiting period of 90 to 180 days and a survival period of 7 to 30 days. In fact, some insurers also offer dedicated cancer insurance plans that provide coverage for pre-existing cancer after the predetermined waiting period is over.

To understand the exact inclusions, exclusions, and other conditions of your policy, you must read all policy documents carefully.

How Much Health Insurance is Required for Myeloma?

Cancer treatment involves surgical procedures, long-term radiation therapy, chemotherapy, etc. A health insurance coverage of at least ₹10 lakh to ₹20 lakh is ideal, considering the high cost of many of these treatments.

However, if you are at higher risk for myeloma because of family history, age or other factors, you should consider opting for a higher sum insured.

FAQs

  • Q1. Is myeloma a serious cancer?

    Ans: Yes, myeloma is a serious and life-threatening blood cancer. It affects the ability of the body to make normal blood cells, it affects the bones, it affects the kidneys, it affects the immune system. But progress in treatment has dramatically improved survival and quality of life for many patients.
  • Q2. Can I live a normal life with myeloma?

    Ans: The ability of a myeloma patient to live a normal life depends on the stage of the disease and its severity. Many people with myeloma are able to live for 5 to 10 years or even longer with early diagnosis, appropriate treatment and regular follow-up care.
  • Q3. What are the first symptoms of myeloma?

    Ans: Early symptoms can include persistent bone pain, particularly in the back, spine, or hips; overwhelming fatigue and weakness; and recurring infections, and in some cases, the disease may produce no symptoms at all in its early stages, making it difficult to detect.
  • Q4. What is the main cause of myeloma?

    Ans: Myeloma begins when a plasma cell in the bone marrow undergoes a genetic mutation, causing it to divide uncontrollably. The exact trigger for this mutation is not known. These mutations are not inherited but develop spontaneously over a person's lifetime, which is why this cancer type is more commonly diagnosed in older adults.
  • Q5. Which organ is most affected by multiple myeloma?

    Ans: Myeloma primarily involves the bone marrow and bones but can also involve the kidneys quite significantly due to the abnormal proteins that myeloma cells produce. The immune system is also severely compromised, and in advanced cases, amyloidosis or hyperviscosity syndrome complications can also affect other organs.
  • Q6. Where does myeloma usually start?

    Ans: Myeloma starts in the bone marrow, the soft spongy tissue found at the centre of larger bones. It can spread across multiple sites where bone marrow is normally active, including the spine, skull, pelvis, rib cage, and the long bones of the arms and legs.
  • Q7. What is the biggest indicator of multiple myeloma?

    Ans: The presence of abnormal proteins known as M proteins or paraproteins in the blood or urine is one of the most significant indicators of myeloma. Bone pain, particularly in the back and spine, along with anaemia and frequent infections, are also commonly observed indicators.
  • Q8. What is the best treatment for myeloma?

    Ans: Treatment of myeloma depends on the stage of the disease and the patient’s overall health. These include targeted therapy, immunotherapy, chemotherapy, corticosteroids, stem cell transplant, radiation therapy, and CAR T-cell therapy. These approaches are often used in combination. The treating doctor determines the most appropriate plan.
  • Q9. At what age does multiple myeloma start?

    Ans: Myeloma is most commonly diagnosed in older adults, with the majority of cases occurring in the late 60s. However, in India, patients tend to be diagnosed a decade earlier than in Western countries. Approximately 8.5% of myeloma cases in India occur in younger adults, while the disease is uncommon below the age of 40, accounting for only around 2% of cases.
  • Q10. Can multiple myeloma spread to other body parts?

    Ans: Myeloma does not spread in the same way as solid tumour cancers. Instead, it is already present across multiple sites in the bone marrow at the time of diagnosis, which is why it is called multiple myeloma. However, complications arising from the disease can affect several organs, including the kidneys, nerves, and in some cases the spinal cord.
  • Q11. Does myeloma run in families?

    Ans: Having a parent or sibling with myeloma can increase the chances of developing this type of cancer. However, myeloma is not considered a hereditary disease, as the mutations that cause it develop spontaneously rather than being inherited.
  • Q12. Who is more prone to myeloma?

    Ans: People over the age of 50, men, those with a family history of myeloma, individuals with obesity, those who have previously been diagnosed with MGUS, and people with long-term exposure to certain chemicals, radiation, or high-risk occupational hazards are considered more prone to developing myeloma.
  • Q13. What are the stages of multiple myeloma?

    Ans: Myeloma has three stages, stage 1 being the least aggressive and stage 3 being the most aggressive.
  • Q14. What blood tests detect myeloma?

    Ans: Blood and urine tests are recommended by doctors to detect abnormal M proteins produced by myeloma cells. They also evaluate blood cell counts, kidney function, and calcium levels. A serum free light chain test may also be used to measure and compare kappa and lambda light chain levels.
  • Q15. Can you fully recover from multiple myeloma?

    Ans: There is currently no permanent cure for myeloma. However, treatment can significantly slow its progression and improve quality of life. The overall five-year survival rate is approximately 62%, rising to around 80% when the condition is detected early. Many people live for 10 years or more with appropriate treatment and follow-up care.